The University of Chicago Header Logo

Search Result Details

Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
Navari, Rudolph
One or more keywords matched the following items that are connected to Navari, Rudolph
Item TypeName
Concept Receptors, Neurokinin-1
Academic Article Reduction of cisplatin-induced emesis by a selective neurokinin-1-receptor antagonist. L-754,030 Antiemetic Trials Group.
Academic Article Use of placebos in delayed-emesis studies.
Academic Article Prevention of cisplatin-induced acute and delayed emesis by the selective neurokinin-1 antagonists, L-758,298 and MK-869.
Academic Article Pathogenesis-based treatment of chemotherapy-induced nausea and vomiting--two new agents.
Academic Article Emerging drugs for chemotherapy-induced emesis.
Academic Article Prevention of emesis from multiple-day and high-dose chemotherapy regimens.
Academic Article Casopitant, a neurokinin-1 receptor antagonist with anti-emetic and anti-nausea activities.
Academic Article Inhibiting substance p pathway for prevention of chemotherapy-induced emesis: preclinical data, clinical trials of neurokinin-1 receptor antagonists.
Academic Article Aprepitant: a neurokinin-1 receptor antagonist for the treatment of chemotherapy-induced nausea and vomiting.
Academic Article Fosaprepitant: a neurokinin-1 receptor antagonist for the prevention of chemotherapy-induced nausea and vomiting.
Academic Article Role of neurokinin-1 receptor antagonists in chemotherapy-induced emesis: summary of clinical trials.
Academic Article Fosaprepitant (MK-0517): a neurokinin-1 receptor antagonist for the prevention of chemotherapy-induced nausea and vomiting.
Academic Article Management of chemotherapy-induced nausea and vomiting : focus on newer agents and new uses for older agents.
Academic Article 5-HT3 receptors as important mediators of nausea and vomiting due to chemotherapy.
Academic Article Rolapitant for the treatment of chemotherapy-induced nausea and vomiting.
Academic Article Efficacy and safety of rolapitant for prevention of chemotherapy-induced nausea and vomiting over multiple cycles of moderately or highly emetogenic chemotherapy.
Academic Article Antiemetic Prophylaxis for Chemotherapy-Induced Nausea and Vomiting.
Academic Article Rolapitant hydrochloride: prophylactic treatment for chemotherapy-induced nausea and vomiting.
Academic Article Rolapitant improves quality of life of patients receiving highly or moderately emetogenic chemotherapy.
Academic Article Management of Chemotherapy-Induced Nausea and Vomiting in Pediatric Patients.
Academic Article Evolving role of neurokinin 1-receptor antagonists for chemotherapy-induced nausea and vomiting.
Academic Article Recent developments in the clinical pharmacology of rolapitant: subanalyses in specific populations.
Academic Article HTX-019: polysorbate 80- and synthetic surfactant-free neurokinin 1 receptor antagonist for chemotherapy-induced nausea and vomiting prophylaxis.
Academic Article The safety of rolapitant for the treatment of nausea and vomiting associated with chemotherapy.
Academic Article Safety profile of HTX-019 administered as an intravenous push in cancer patients: a retrospective review.
Concept Neurokinin-1 Receptor Antagonists
Academic Article Olanzapine With or Without Fosaprepitant for Preventing Chemotherapy Induced Nausea and Vomiting in Patients Receiving Highly Emetogenic Chemotherapy: A Phase III Randomized, Double-Blind, Placebo-Controlled Trial (ALLIANCE A221602).
Search Criteria
  • Receptors Neurokinin 2